Literature DB >> 3197077

Localization and identification of nuclear radioactivity in the pituitary gland and genital tract after administering 3H-testosterone, 3H-dihydrotestosterone, or 3H-estradiol to male rhesus monkeys.

H D Rees1, R W Bonsall, R P Michael.   

Abstract

Target cells for testosterone, dihydrotestosterone, and estradiol in the pituitary gland and genital tract of the male primate were localized by thaw-mount autoradiography, and high performance liquid chromatography was used to identify the metabolites of these steroids in cell nuclei. Castrated rhesus monkeys were injected with 3H-testosterone, 3H-dihydrotestosterone, or 3H-estradiol and killed 60 min later. In the anterior pituitary gland, fewer cells were labeled and less radioactivity was taken up by cell nuclei following the administration of either 3H-testosterone (4% of pars distalis cells and 5 dpm/micrograms DNA) or 3H-dihydrotestosterone (5% of cells and 13 dpm/micrograms DNA) than following the administration of 3H-estradiol (43% of cells and 214 dpm/micrograms DNA). Most of the radioactivity in nuclei was in the form of the unmetabolized parent compound (78-94%). In prostate, seminal vesicles, and penis, 3H-dihydrotestosterone was the predominant form of nuclear radioactivity following both 3H-testosterone (67-90%) and 3H-dihydrostestosterone (94-97%) administration, and both androgens labeled epithelial and smooth muscle cells. In contrast, 3H-estradiol was taken up in unchanged form, by cell nuclei of the genital tract and it labeled connective tissue fibroblasts, but not epithelial cells. Thus, the distributions of target cells for androgens and estrogens were clearly different in all these tissues, and the uptake of testosterone resembled that of its androgenic rather than that of its estrogenic metabolite.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197077     DOI: 10.1007/bf00220027

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  44 in total

1.  Immunocytochemical assay for estrogen receptors applied to human prostatic tumors.

Authors:  M E Harper; P E Sibley; A B Francis; R I Nicholson; K Griffiths
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

2.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

3.  Separate negative feedback effects of estrogen on the pituitary and the central nervous system in the ovariectomized rhesus monkey.

Authors:  R F Weick; V Pitelka; D L Thompson
Journal:  Endocrinology       Date:  1983-05       Impact factor: 4.736

4.  Negative feedback control of gonadotropins in male rhesus monkeys: effects of time after castration and interactions of testosterone and estradiol-17beta.

Authors:  J A Resko; S K Quadri; H G Spies
Journal:  Endocrinology       Date:  1977-07       Impact factor: 4.736

5.  Studies on the androgen receptor of the rat seminal vesicle: comparison of the binding characteristics of dihydrotestosterone and testosterone.

Authors:  T Zakár; M Tóth
Journal:  J Steroid Biochem       Date:  1980-07       Impact factor: 4.292

6.  Effects of orchidectomy and testosterone replacement treatment on pulsatile luteinizing hormone secretion in the adult rhesus monkey (Macaca mulatta).

Authors:  T M Plant
Journal:  Endocrinology       Date:  1982-06       Impact factor: 4.736

7.  Regulation of brain aromatase activity in rats.

Authors:  C E Roselli; W E Ellinwood; J A Resko
Journal:  Endocrinology       Date:  1984-01       Impact factor: 4.736

8.  Androgen receptors in the prostate of the Rhesus monkey.

Authors:  R Ghanadian; G Auf; C B Smith; G D Chisholm; N J Blacklock
Journal:  Urol Res       Date:  1977

9.  [3H]estradiol and its metabolites in the brain, pituitary gland, and reproductive tract of the male rhesus monkey. A combined autoradiographic and chromatographic study.

Authors:  R W Bonsall; H D Rees; R P Michael
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

10.  Heterogeneity of steroid binding sites in prostatic carcinoma: morphological demonstration and clinical implications.

Authors:  L P Pertschuk; K B Eisenberg; R J Macchia; J G Feldman
Journal:  Prostate       Date:  1985       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.